Full-Time

Reliability Engineer

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Portadown, Craigavon, UK

In Person

Category
DevOps & Infrastructure (1)
Required Skills
Visio
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Minimum of 5 years’ experience in a pharmaceutical, medical device or similar environment.
  • Experience in change control, management of change, non-conformance, corrective and preventative actions and validation practices.
  • Excellent communication skills, both verbal and written.
  • Knowledge of pharmaceutical packaging equipment, packaging materials, technologies and challenges with each.
  • Experience in a GMP or Regulated Environment.
  • Proficient utilisation of software packages such as Excel, Word, PowerPoint, Project and Visio and a high level of computer literacy.
  • Ability to manage multiple tasks and set priorities.
  • Problem Solving and Troubleshooting skills. The successful candidate should display a dynamic and proactive approach to manage problems.
  • Self-motivated with a results driven approach.
  • Adaptable and ability to work collaboratively.
  • Effective communication – internal and external.
  • Team working – display obvious signs of ability to work in high performing complex teams.
  • Committed to the highest levels of integrity, ethics and professionalism.
  • Excellent analytical and critical thinking skills with a record of successfully change management.
Responsibilities
  • Analyse current processes to assess performance, identify improvement opportunities for equipment reliability, preventive and predictive maintenance, and condition monitoring.
  • Lead technical root cause analysis, incident investigations and troubleshooting issues related to manufacturing equipment / systems.
  • Using SMED principles identify opportunities to improve the consistency and RFT of our batch change-over / machine setting activities.
  • Assist the Project Engineering function with the transfer of new equipment from the validation to commercial phase of our NPI projects.
  • Implement a critical spares program based on OEM specifications, ongoing maintenance programs and the predictive maintenance program.
  • Ensure the calibration of all relevant engineering equipment is maintained appropriately.
  • Lead and support system improvements, development of detailed specifications, engineering documents and standard operating procedures.
  • Solving complex problems, project management, equipment lifecycle management and operational excellence.
  • Support a safe working environment by complying with all pertinent environmental health/safety practice, rules and regulations.
  • Work with the Continuous Improvement team and Department Managers to deliver operational excellence within PCI Ireland focusing on the warehouse functions.
  • Design, implement, review and action critical KPIs for processing equipment.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at PCI Pharma Services who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.